Novo Nordisk's 20%+ price drop since yesterday following a significant downgrade in sales and profit guidance is a great buying opportunity. The stock's forward P/E is at half the stock's five-year av...On this page, we offer a checklist to help you find the company right for you. However, we Perro sum it up for you right away, if you want to call